Drug
Who makes potassium phosphates?
6 companies list potassium phosphates as a human prescription drug. Forms: injection; injection, solution; injection, solution, concentrate. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing potassium phosphates
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Glenmark Pharmaceuticals Inc., USAIndia | injection, solution, concentrate | ANDAANDA220373 | 3 | 9 |
| CIPLA PHARMACEUTICALS LIMITEDIndia | injection | ANDAANDA217892 | 3 | 7 |
| CAPLIN STERILES LIMITEDIndia | injection, solution, concentrate | ANDAANDA220373 | 3 | 1 |
| Fresenius Kabi USA, LLCUnited States | injection, solution | NDANDA212832 | 2 | 6 |
| Hospira, Inc.United States | injection, solution, concentrate | ANDAANDA217459 | 1 | 7 |
| American Regent, Inc.United States | injection, solution | ANDAANDA216274 | 1 | 5 |
Enquiry
Common questions
- Who makes potassium phosphates?
- 6 companies list potassium phosphates as a human prescription drug in the openFDA NDC Directory, led by Glenmark Pharmaceuticals Inc., USA, CIPLA PHARMACEUTICALS LIMITED, CAPLIN STERILES LIMITED, Fresenius Kabi USA, LLC, Hospira, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic potassium phosphates?
- 5 companies list potassium phosphates under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.